--- title: "Haleon (HLN) stock listing, news and investor profile" url: "https://aibio.space/companies/haleon/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Haleon PLC (LSE: HLN), United Kingdom. The directory classifies it as Pharmaceuticals: Major." --- HLN Haleon PLC LSE · United Kingdom # Haleon (HLN) news Haleon PLC is a public biotech or pharmaceutical company listed on LSE under the ticker HLN, recorded under United Kingdom. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Haleon news We have not published a story on Haleon yet. When there is news, it will appear here. ## Haleon at a glance - **Ticker**: HLN - **Listing**: LSE - **Country**: United Kingdom - **Cash, Dec 31, 2025**: £1.32 billion ### Related companies - [Shield Therapeutics Plc](https://aibio.space/companies/shield-therapeutics/) LSE: STX - [AstraZeneca](https://aibio.space/companies/astrazeneca/) LSE: AZN - [Kiniksa Pharmaceuticals International](https://aibio.space/companies/kiniksa-pharmaceuticals-international/) NASDAQ: KNSA - [Coiled Therapeutics Plc](https://aibio.space/companies/coiled-therapeutics/) LSE: COIL - [Poolbeg Pharma](https://aibio.space/companies/poolbeg-pharma/) LSE: POLB - [Roivant Sciences](https://aibio.space/companies/roivant-sciences/) NASDAQ: ROIV - [Bicycle Therapeutics](https://aibio.space/companies/bicycle-therapeutics/) NASDAQ: BCYC - [Autolus Therapeutics](https://aibio.space/companies/autolus-therapeutics/) NASDAQ: AUTL ### Also on LSE - [Poolbeg Pharma](https://aibio.space/companies/poolbeg-pharma/) POLB - [ImmuPharma](https://aibio.space/companies/immupharma/) IMM - [PureTech Health](https://aibio.space/companies/puretech-health/) PRTC - [Shield Therapeutics Plc](https://aibio.space/companies/shield-therapeutics/) STX - [Aptamer Group Plc](https://aibio.space/companies/aptamer/) APTA - [Bioventix Plc](https://aibio.space/companies/bioventix/) BVXP ## Haleon annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [£11.03 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | [£11.23 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | | Research and development | [£316.0 million](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | [£298.0 million](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | | Net income (loss) | [£1.68 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | [£1.48 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | | Cash from operations | [£2.63 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | [£2.30 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | | Cash and equivalents | [£1.32 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | [£2.25 billion](https://www.sec.gov/Archives/edgar/data/1900304/000110465926027443/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents £1.32 billion. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Haleon What is the ticker symbol of Haleon? Haleon PLC trades under the ticker HLN on LSE. Where is Haleon listed? Haleon PLC is listed on LSE. Our directory also records these other listings: BMV:HLN1/N; DUS:H6D0; FWB:H6D0; GETTEX:H6D0; HAM:H6D0; HAN:H6D0; LS:A3DNZQ; LSX:A3DNZQ; MUN:H6D0; NYSE:HLN; OTC:HLNCF; SWB:H6D0; TRADEGATE:H6D0; XETR:H6D0. What is the SEC CIK of Haleon? The SEC Central Index Key (CIK) for Haleon PLC is 1900304. Its filings are on SEC EDGAR. How many shares does Haleon have outstanding? 8,952,353,648 shares as of 2026-03-13, per the cover page of its 20-F filed 2026-03-13. Which country or territory is Haleon listed under? Our directory records Haleon PLC under United Kingdom. What does Haleon do? Our directory classifies Haleon PLC as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Haleon? The ISIN recorded for Haleon PLC is GB00BMX86B70. Does aibio.space cover Haleon? aibio.space lists Haleon PLC among 2,820 public biotech companies and publishes its news here as stories appear. Where is Haleon incorporated? SEC records list its state or country of incorporation as X0. Is Haleon a smaller reporting company? SEC records list Haleon PLC's filer category as: Large accelerated filer. Where is Haleon headquartered? SEC records list its business address as BUILDING 5, FIRST FLOOR, WEYBRIDGE, United Kingdom, KT13 0NY. When does Haleon's fiscal year end? Haleon PLC's fiscal year ends on December 31, per SEC records. What did Haleon last file with the SEC? Its most recent filing in our record is a 6-K filed 2026-10-01. All of its filings are on SEC EDGAR. [Source](https://www.sec.gov/Archives/edgar/data/1900304/000165495426008695/a0531x.htm). What was Haleon called before? SEC records list these former names: DRVW 2022 Ltd. What industry is Haleon in? Its SEC industry code (SIC 2844) is Perfumes, Cosmetics & Other Toilet Preparations. ## Investor discussion: Haleon Members talk about Haleon (HLN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Haleon, newest first. Each line links the filing it comes from. 1. 2026-08-11 Financings Filed a final prospectus for a securities offering. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1900304/000110465926093822/tm2622443-1_424b5.htm) 2. 2026-08-11 Mergers Reported a merger or acquisition agreement. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1900304/000165495426007448/a2418q.htm) 3. 2025-07-31 Financings Announced a share repurchase program. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1900304/000165495425008670/a2906t.htm) 4. 2025-03-28 Financings Announced a share repurchase program. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1900304/000165495425003467/a5876c.htm) 5. 2024-10-31 Financings Announced a share repurchase program. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1900304/000155837024014001/hln-20241031xex99d1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open LSE:HLN on TradingView](https://www.tradingview.com/symbols/LSE-HLN/). ## SEC filings and registration - **SEC name**: Haleon plc - **CIK**: 1900304 - **Industry (SIC)**: Perfumes, Cosmetics & Other Toilet Preparations (2844) - **US tickers**: HLN (NYSE), HLNCF (OTC) - **State or country of incorporation**: X0 - **Fiscal year ends**: December 31 - **Filer category**: Large accelerated filer - **Business address**: BUILDING 5, FIRST FLOOR, WEYBRIDGE, United Kingdom, KT13 0NY - **Phone**: 44 1932 822000 - **Shares outstanding**: 8,952,353,648 as of 2026-03-13 (20-F filed 2026-03-13) - **Former names**: DRVW 2022 Ltd ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426008695/a0531x.htm) filed 2026-10-01 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426008547/a1939w.htm) filed 2026-09-24 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426008440/a4160v.htm) filed 2026-09-18 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426008000/a6350s.htm) filed 2026-09-01 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000110465926099613/tm2623597d2_6k.htm) filed 2026-08-21 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426007739/a3216r.htm) filed 2026-08-19 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426007733/a2093r.htm) filed 2026-08-19 - [6-K](https://www.sec.gov/Archives/edgar/data/1900304/000165495426007675/a8343q.htm) filed 2026-08-17 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001900304), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Haleon PLC is a public biotech or pharmaceutical company listed on LSE under the ticker HLN, recorded under United Kingdom. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Haleon PLC - **Ticker**: HLN - **Listing**: LSE - **Country or territory**: United Kingdom - **Business scope**: Pharmaceuticals: Major - **ISIN**: GB00BMX86B70 - **Other listed symbols**: BMV:HLN1/N; DUS:H6D0; FWB:H6D0; GETTEX:H6D0; HAM:H6D0; HAN:H6D0; LS:A3DNZQ; LSX:A3DNZQ; MUN:H6D0; NYSE:HLN; OTC:HLNCF; SWB:H6D0; TRADEGATE:H6D0; XETR:H6D0 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/LSE-HLN/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/haleon/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Haleon (HLN) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/haleon/